Venlafaxine Hydrochloride 150 mg Capsule, Extended Release, 30-count — NDC 70771-1838-3 (Billing 70771-1838-03)
This is a package of 30 capsules of Venlafaxine Hydrochloride 150 mg Capsule, Extended Release from Zydus Lifesciences Limited, marketed since May 2023 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 70771-1838-3 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 70771 labeler · 1838 product · 3 package
- Package marketed since
- May 18, 2023
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC)
- 0370771183890
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 313581
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 3, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Serotonin and Norepinephrine Reuptake Inhibitor class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
Venlafaxine is used to treat depression, generalized anxiety disorder (GAD; excessive worrying that is difficult to control), social anxiety disorder (extreme fear of interacting with others or performing in front of others that interferes with normal life), and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Venlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental bala...
Read the full MedlinePlus article ↗- It treats major depressive disorder. Depending on the product, it is also used for social anxiety disorder, generalized anxiety disorder and panic disorder. Your pharmacist can con...
- Take extended-release forms once a day with food, at about the same time each day. Swallow tablets and capsules whole. A capsule can be opened onto applesauce if swallowing is hard...
- Nausea, sleepiness, dry mouth, sweating, constipation and loss of appetite are common. Some people have sexual side effects. Call your doctor if side effects are severe or don’t ea...
- Please don’t stop suddenly. Stopping or cutting the dose quickly can cause dizziness, nausea, anxiety, insomnia and electric-shock feelings. Your prescriber will lower the dose gra...
Patient education
Supplement & herbal interactions
Venlafaxine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 3, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.2146 | $6.44 / 30 capsules |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 4, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 70771-1838-00 70771-1838-0 Main listing | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2023-05-18 | — | Active |
| 70771-1838-03 You're viewing this | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2023-05-18 | — | Active |
| 70771-1838-04 70771-1838-4 | 10 BLISTER PACK in 1 CARTON / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK | 2023-05-18 | — | Active |
| 70771-1838-05 70771-1838-5 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2023-05-18 | — | Active |
| 70771-1838-09 70771-1838-9 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 2023-05-18 | — | Active |
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 70771-1838-09?
What NDC number is used to bill for this package of Venlafaxine Hydrochloride 150 mg Capsule, Extended Release?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride 150 mg 00093-7386-05 | Teva | 500 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 00904-7489-61 | Major | 1 capsule | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 42806-0603-05 | Epic | 500 capsules | $0.119 | AB | Availability likely | — |
| venlafaxine hydrochloride 150 mg 43598-0002-05 | Dr.Reddys | 500 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 50268-0875-15 | AvPAK | 1 capsule | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 65862-0697-01 | Aurobindo | 100 capsules | $0.119 | — | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 68084-0713-01 | American | 1 capsule | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 70010-0186-03 | Granules | 30 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 70710-1700-00 | Zydus | 1000 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 72603-0749-01 | NorthStar | 90 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine Hydrochloride 150 mg 82009-0058-05 | QUALLENT | 500 capsules | $0.119 | AB | Availability likely | — |
| Venlafaxine hydrochloride 150 mg 33342-0196-07 | Macleods | 30 capsules | $0.139 | AB | FDA listed | — |
| Effexor XR 150 mg 58151-0127-77 | Viatris | 90 capsules | $21.622 | AB | Availability likely | — |
| Effexor XR 150 mg 00008-0836-21 | Wyeth | 30 capsules | $21.625 | AB | Discontinued | — |
| Venlafaxine Hydrochloride 150 mg 00615-8510-39 | NCS | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 10135-0827-10 | Marlex | 1000 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 31722-0004-01 | Camber | 10 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 42291-0899-30 | AvKARE | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 46708-0794-30 | Alembic | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-2519-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-5890-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-6896-00 | A-S | 90 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-7323-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-7324-00 | A-S | 90 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 50090-7942-00 | A-S | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 150 mg 55111-0455-01 | Dr.Reddy's | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 62332-0794-30 | Alembic | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 63187-0420-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 150 mg 65841-0753-06 | Zydus | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 67046-1656-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 68071-3727-09 | NuCare | 90 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 150 mg 68071-4442-09 | NuCare | 90 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 68071-5020-09 | NuCare | 90 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 150 mg 68382-0036-06 | Zydus | 30 capsules | — | AB | FDA listed | — |
| venlafaxine hydrochloride 150 mg 68788-6806-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 68788-8072-03 | Preferred | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 68788-8752-03 | Preferred | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 68788-8774-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 70518-2259-00 | REMEDYREPACK | 90 capsules | — | AB | Discontinued | — |
| Venlafaxine Hydrochloride 150 mg 70518-4154-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mgthis 70771-1838-03 | Zydus | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 71335-1642-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 71335-1812-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 71335-2495-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 71335-2992-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 71785-1008-00 | Annora | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 72888-0181-30 | Advagen | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 76420-0632-01 | Asclemed | 100 capsules | — | AB | FDA listed | — |
| Venlafaxine HCL ER 150 mg 80425-0194-02 | Advanced | 60 capsules | — | AB | FDA listed | — |
| Venlafaxine hydrochloride ER 150 mg 80425-0297-01 | Advanced | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 82804-0038-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| Venlafaxine Hydrochloride 150 mg 24658-0127-05 | PURACAP | 500 capsules | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII H3UP11403C
Ethylcellulose is a plant-derived polymer that thickens and forms protective coatings on tablets and capsules. It slows medicine release into the body and protects the contents from moisture and air.
-
UNII 1K09F3G675
Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
-
UNII XM0M87F357
A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
-
UNII 2G86QN327L
Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
-
UNII 36SFW2JZ0W
Hypromellose 2910 is a plant-based thickening agent derived from cellulose. In medicines, it forms a protective coating on tablets or capsules and controls how quickly the drug dissolves and releases into your body.
-
UNII R75537T0T4
Hypromellose 2910 is a plant-derived thickening agent made from cellulose. It serves as a binder that holds tablet ingredients together, a film-coating for pills, and a viscosity controller in liquids.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII Q662QK8M3B
Polyethylene glycol 8000 is a synthetic polymer made from ethylene oxide. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and add bulk to the medicine.
-
UNII WZH3C48M4T
Potassium hydroxide is a strong alkaline chemical used in medicines to adjust and maintain the pH level of liquid formulations, helping keep the product stable and the active ingredients effective.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 46N107B71O
Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
-
UNII 7SEV7J4R1U
A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
15 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 3, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Zydus Lifesciences Limited labeler code 70771
- acetaZOLAMIDE 125 mg Tablet NDC 70771-1827-1
- acetaZOLAMIDE 250 mg Tablet NDC 70771-1828-1
- Sucralfate 1 g Tablet NDC 70771-1833-1
- Metronidazole 7.5 mg/g Cream NDC 70771-1834-4
- Venlafaxine Hydrochloride 37.5 mg Capsule, Extended Release NDC 70771-1836-0
- Venlafaxine Hydrochloride 75 mg Capsule, Extended Release NDC 70771-1837-0
- balsalazide disodium 750 mg Capsule NDC 70771-1841-1
- oxcarbazepine 150 mg Tablet NDC 70771-1842-1
- oxcarbazepine 300 mg Tablet NDC 70771-1843-0
- oxcarbazepine 600 mg Tablet NDC 70771-1844-1
- zinc sulfate 1 mg/mL Injection, Solution NDC 70771-1848-7
- zinc sulfate 3 mg/mL Injection, Solution NDC 70771-1849-7
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 Package Label / Principal Display Panel ▾
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1836-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 37.5 mg 90 Capsules Rx only NDC 70771-1837-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 75 mg 90 Capsules Rx only NDC 70771-1838-9 Venlafaxine Hydrochloride Extended-release Capsules USP, 150 mg 90 Capsules Rx only 37.5 mg label 75 mg label 150 mg label
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |